Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

Similar articles for PubMed (Select 11333995)

1.

Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.

Barry MJ.

N Engl J Med. 2001 May 3;344(18):1373-7. Review. No abstract available.

PMID:
11333995
2.

[Re: Implementation of guidelines for PSA testing in general practice].

Eri LM.

Tidsskr Nor Laegeforen. 2015 Jan 13;135(1):15. doi: 10.4045/tidsskr.14.1494. eCollection 2015 Jan 13. Norwegian. No abstract available.

3.

PSA test not recommended by Canadian Task Force.

Tanday S.

Lancet Oncol. 2014 Dec;15(13):e589. doi: 10.1016/S1470-2045(14)71111-8. Epub 2014 Oct 31. No abstract available.

PMID:
25499287
4.

[Implementation of guidelines for PSA testing in general practice].

Jodal HC, Reyes YD, Roksund G, Bretthauer M.

Tidsskr Nor Laegeforen. 2014 Nov 11;134(21):2032-4. doi: 10.4045/tidsskr.14.0982. eCollection 2014 Nov 11. Norwegian. No abstract available.

5.

Falling through the cracks: New Zealand prostate cancer survivors' experiences and views regarding PSA testing.

Patel A, MacLeod R, Masters J, Keogh J.

N Z Med J. 2014 Aug 15;127(1400):106-9. No abstract available.

PMID:
25145373
6.

[What about the contribution of genetics in prostate cancer screening?].

Nau JY.

Rev Med Suisse. 2014 Jul 16;10(437):1474-5. French. No abstract available.

PMID:
25141570
7.

Prostate cancer: summary of updated NICE guidance.

Graham J, Kirkbride P, Cann K, Hasler E, Prettyjohns M.

BMJ. 2014 Jan 8;348:f7524. doi: 10.1136/bmj.f7524. No abstract available.

PMID:
24401467
8.

Liaise with pathologists to refine understanding of the prostate-specific antigen test.

Sikaris KA, Ross BA, Khong TY.

Med J Aust. 2013 Nov 18;199(10):656, 658. No abstract available.

PMID:
24237087
9.

Prostate cancer screening and ethical use of limited resources.

Ragupathy R, Menkes DB.

N Z Med J. 2013 Nov 1;126(1385):92-4. No abstract available.

PMID:
24217598
10.

Re: Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.

Penson DF.

J Urol. 2013 Nov;190(5):1766. doi: 10.1016/j.juro.2013.07.078. Epub 2013 Aug 2. No abstract available.

PMID:
24120783
11.

Prostate cancer: Prostate Health Index--improving screening in men with family history.

Loeb S.

Nat Rev Urol. 2013 Sep;10(9):497-8. doi: 10.1038/nrurol.2013.169. Epub 2013 Aug 13. No abstract available.

PMID:
23938945
12.

Group now advises against routine PSA screening.

Mitka M.

JAMA. 2013 Jun 12;309(22):2316. doi: 10.1001/jama.2013.6922. No abstract available.

PMID:
23757064
13.

Evidence does not support routine PSA testing, say experts.

McCarthy M.

BMJ. 2013 May 9;346:f2982. doi: 10.1136/bmj.f2982. No abstract available.

PMID:
23661116
14.

Prostate-specific antigen screening for prostate cancer: why so much controversy?

Labrie F.

Int J Urol. 2013 Nov;20(11):1148. doi: 10.1111/iju.12162. Epub 2013 Apr 15. No abstract available.

PMID:
23586435
15.

Harms of PSA screening outweigh benefits for most men, says American College of Physicians.

McCarthy M.

BMJ. 2013 Apr 9;346:f2232. doi: 10.1136/bmj.f2232. No abstract available.

PMID:
23571746
16.

Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

[No authors listed]

Ann Intern Med. 2013 May 21;158(10):I-28. doi: 10.7326/0003-4819-158-10-201305210-00634. No abstract available.

PMID:
23567761
17.

Screening for prostate cancer.

Croswell J, Shin YR.

Am Fam Physician. 2013 Feb 15;87(4):283-4. No abstract available.

18.
19.

Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.

Nam RK, Oliver TK, Vickers AJ, Thompson I, Kantoff PW, Parnes HL, Loblaw A, Roth BJ, Williams J, Temin S, Basch E.

J Oncol Pract. 2012 Sep;8(5):315-7. doi: 10.1200/JOP.2012.000715. No abstract available.

20.

PSA: Please Stop Agonizing (over prostate-specific antigen interpretation).

Raghavan D.

Mayo Clin Proc. 2013 Jan;88(1):1-3. doi: 10.1016/j.mayocp.2012.11.004. No abstract available.

PMID:
23274013
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk